Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Fortress Biotech (FBIO) Return on Assets (2016 - 2025)

Historic Return on Assets for Fortress Biotech (FBIO) over the last 13 years, with Q3 2025 value amounting to 0.44%.

  • Fortress Biotech's Return on Assets rose 4300.0% to 0.44% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.44%, marking a year-over-year increase of 4300.0%. This contributed to the annual value of 0.78% for FY2024, which is 1100.0% down from last year.
  • Fortress Biotech's Return on Assets amounted to 0.44% in Q3 2025, which was up 4300.0% from 0.66% recorded in Q2 2025.
  • Over the past 5 years, Fortress Biotech's Return on Assets peaked at 0.28% during Q1 2021, and registered a low of 1.06% during Q3 2023.
  • Its 5-year average for Return on Assets is 0.65%, with a median of 0.66% in 2025.
  • Its Return on Assets has fluctuated over the past 5 years, first crashed by -4400bps in 2023, then surged by 4300bps in 2025.
  • Fortress Biotech's Return on Assets (Quarter) stood at 0.46% in 2021, then tumbled by -47bps to 0.67% in 2022, then crashed by -37bps to 0.92% in 2023, then increased by 7bps to 0.86% in 2024, then skyrocketed by 49bps to 0.44% in 2025.
  • Its last three reported values are 0.44% in Q3 2025, 0.66% for Q2 2025, and 0.63% during Q1 2025.